Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Gene Silencing/Gene Editing » Sirna, Alnylam, Cenix, Bayer, Fisher, Cellomics, CytRx, Nastech, Isis, Lilly, Qiagen, Xantos, Bio-Rad

Sirna, Alnylam, Cenix, Bayer, Fisher, Cellomics, CytRx, Nastech, Isis, Lilly, Qiagen, Xantos, Bio-Rad

Aug 12, 2005
Premium

Sirna Posts Higher Q2 Revenues, Lower Losses

Sirna Therapeutics reported this week a sharp increase in second-quarter revenues, which helped to push down the company's losses.

The company posted revenues of $1.5 million in the quarter, up from $454,000 in the year-ago period, reflecting a surge in fees received from contract manufacturing services.

Sirna's second-quarter net loss arrived at $5.9 million, or $0.14 per share, versus $6.3 million, or $0.18 per share a year earlier.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Vaccine Supply Chain Hacker Warning

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

Illinois Cuts Forensic Testing Backlog

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

Lying Plea

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

Science Studies on Nonalcoholic Fatty Liver Disease Expression Signatures, Ties Between Gut Microbiome and Major Depression

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.

Dec
10
Featured Webinar

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.